Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

Part of paid clinical trials in Hot Springs, Arkansas.

Sponsor
Bristol-Myers Squibb
Study ID
NCT05478499
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Deucravacitinib — DRUG
    Specified dose on specified days
  • Placebo — OTHER
    Specified dose on specified days

Study Details

The purpose of this study is to compare the efficacy and safety of deucravacitinib to placebo in participants with moderate-to-severe scalp psoriasis.

Key Dates

Start date
Oct 6, 2022
Status verified
Sep 2025
Primary completion
Jan 11, 2024
Completion
Oct 17, 2024

Study Design

Enrollment
154 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Deucravacitinib
  • Placebo Comparator: Placebo then Deucravacitinib

Primary Outcome Measure

Percentage of Participants With a Scalp-specific Physician Global Assessment Score of 0 or 1 (Ss-PGA 0/1) at Week 16 [ Time Frame: Baseline and Week 16 ]

Locations (14)

FacilityCityStateZIPSite coordinators
Local Institution - 0001Hot SpringsArkansas71913-
Local Institution - 0007IndianapolisIndiana46256-
Local Institution - 0041LouisvilleKentucky40217-
Local Institution - 0022RockvilleMaryland20850-
Local Institution - 0008BeverlyMassachusetts01915-
Local Institution - 0047Bloomfield HillsMichigan48302-
Local Institution - 0002New BrightonMinnesota55432-
Local Institution - 0049East WindsorNew Jersey08520-
Local Institution - 0051Kew GardensNew York11415-
Local Institution - 0003PortlandOregon97201-
Local Institution - 0005PittsburghPennsylvania15213-
Local Institution - 0033HoustonTexas77004-
Local Institution - 0004San AntonioTexas78229-
Local Institution - 0006NorfolkVirginia23502-

Related coverage on Hipa.ai

Find similar trials in Hot Springs, AR

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Local Institution - 0001· Hot Springs, ARLocal Institution - 0007· Indianapolis, INLocal Institution - 0041· Louisville, KYLocal Institution - 0022· Rockville, MDLocal Institution - 0008· Beverly, MALocal Institution - 0047· Bloomfield Hills, MI

Related Studies